Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.
Di Cosimo S, Triulzi T, Pizzamiglio S, De Cecco L, de Azambuja E, Fumagalli D, Putzai L, Harbeck N, Izquierdo M, Peña L, Daidone MG, Huober J, Gori S, Cinieri S, Torri V, Baselga J, Piccart M, de Braud FG, Apolone G, Verderio P, Tagliabue E. Di Cosimo S, et al. Among authors: tagliabue e. Eur J Cancer. 2019 Sep;118:1-9. doi: 10.1016/j.ejca.2019.06.001. Epub 2019 Jul 5. Eur J Cancer. 2019. PMID: 31284184 Free article.
c-erbB-2 expression in primary breast cancer.
Tagliabue E, Ménard S, Robertson JF, Harris L. Tagliabue E, et al. Int J Biol Markers. 1999 Jan-Mar;14(1):16-26. doi: 10.1177/172460089901400104. Int J Biol Markers. 1999. PMID: 10367245 Free article. Review.
Role of HER2 in wound-induced breast carcinoma proliferation.
Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Ménard S. Tagliabue E, et al. Lancet. 2003 Aug 16;362(9383):527-33. doi: 10.1016/S0140-6736(03)14112-8. Lancet. 2003. PMID: 12932384
Biologic and therapeutic role of HER2 in cancer.
Ménard S, Pupa SM, Campiglio M, Tagliabue E. Ménard S, et al. Among authors: tagliabue e. Oncogene. 2003 Sep 29;22(42):6570-8. doi: 10.1038/sj.onc.1206779. Oncogene. 2003. PMID: 14528282 Review.
Role of exon-16-deleted HER2 in breast carcinomas.
Castiglioni F, Tagliabue E, Campiglio M, Pupa SM, Balsari A, Ménard S. Castiglioni F, et al. Among authors: tagliabue e. Endocr Relat Cancer. 2006 Mar;13(1):221-32. doi: 10.1677/erc.1.01047. Endocr Relat Cancer. 2006. PMID: 16601290
Radiation effects on development of HER2-positive breast carcinomas.
Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T, Sozzi G, Fossati-Bellani F, Ménard S, Tagliabue E. Castiglioni F, et al. Among authors: tagliabue e. Clin Cancer Res. 2007 Jan 1;13(1):46-51. doi: 10.1158/1078-0432.CCR-06-1490. Clin Cancer Res. 2007. PMID: 17200337
Regulation of breast cancer response to chemotherapy by fibulin-1.
Pupa SM, Giuffré S, Castiglioni F, Bertola L, Cantú M, Bongarzone I, Baldassari P, Mortarini R, Argraves WS, Anichini A, Menard S, Tagliabue E. Pupa SM, et al. Among authors: tagliabue e. Cancer Res. 2007 May 1;67(9):4271-7. doi: 10.1158/0008-5472.CAN-06-4162. Cancer Res. 2007. PMID: 17483339
343 results